TrialBlood2012
Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma.
Anas Younes et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
24 papers cite it
this paperpooled ittrialcites it
TrialBlood2012
Anas Younes et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.